Michael Howard Bloch - Publications

Affiliations: 
Yale University, New Haven, CT 
Area:
OCD, trichotillomania

114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety. PMID 30479005 DOI: 10.1002/da.22854  0.36
2018 Taylor JH, Jakubovski E, Gabriel D, Bloch MH. Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study. Journal of Child and Adolescent Psychopharmacology. PMID 29920116 DOI: 10.1089/cap.2017.0147  0.36
2018 Asarnow J, Bloch MH, Brandeis D, Alexandra Burt S, Fearon P, Fombonne E, Green J, Gregory A, Gunnar M, Halperin JM, Hollis C, Jaffee S, Klump K, Landau S, Lesch KP, et al. Special Editorial: Open science and the Journal of Child Psychology & Psychiatry - next steps? Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 29806217 DOI: 10.1111/jcpp.12929  0.32
2017 Wilkinson ST, Sanacora G, Bloch MH. Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 327-335. PMID 28989984 DOI: 10.1016/j.bpsc.2017.01.011  0.72
2017 Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, Sos P, Wang G, Zarate CA, Sanacora G. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. The American Journal of Psychiatry. appiajp201717040472. PMID 28969441 DOI: 10.1176/appi.ajp.2017.17040472  0.72
2017 Taylor JH, Lebowitz ER, Jakubovski E, Coughlin CG, Silverman WK, Bloch MH. Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 1-16. PMID 28956620 DOI: 10.1080/15374416.2017.1371028  0.36
2017 Taylor JH, Landeros-Weisenberger A, Coughlin C, Mulqueen J, Johnson JA, Gabriel D, Reed MO, Jakubovski E, Bloch MH. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28849779 DOI: 10.1038/npp.2017.194  0.36
2017 Johnson JA, Jakubovski E, Reed MO, Bloch MH. Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 28771386 DOI: 10.1089/cap.2017.0025  0.36
2017 Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH, Miguel EC, Shavitt RG. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. PMID 28617566 DOI: 10.4088/JCP.16m11101  0.64
2017 Gabriel D, Jakubovski E, Taylor JH, Artukoglu BB, Bloch MH. Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study. Psychiatry Research. 255: 248-255. PMID 28595147 DOI: 10.1016/j.psychres.2017.05.038  0.36
2017 Dwyer JB, Beyer C, Wilkinson ST, Ostroff RB, Qayyum Z, Bloch MH. Ketamine as a Treatment for Adolescent Depression: A Case Report. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 352-354. PMID 28335880 DOI: 10.1016/j.jaac.2017.01.006  0.72
2017 Reed MO, Jakubovski E, Johnson JA, Bloch MH. Predictors of Long-Term School-Based Behavioral Outcomes in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 28253029 DOI: 10.1089/cap.2015.0168  0.36
2017 Adams TG, Bloch MH, Pittenger C. Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology. PMID 28121735 DOI: 10.1097/JCP.0000000000000659  0.64
2016 Varigonda AL, Jakubovski E, Bloch MH. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 851-859.e2. PMID 27663940 DOI: 10.1016/j.jaac.2016.07.768  0.36
2016 Coughlin CG, Jakubovski E, Bloch MH. Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial. The Journal of Clinical Psychiatry. PMID 27631142 DOI: 10.4088/JCP.15m10075  0.36
2016 Jakubovski E, Bloch MH. Addressing Difficulties in the Study of Dose-Response Relationships of SSRIs in Depression: Response to Hieronymus and Eriksson. The American Journal of Psychiatry. 173: 836-8. PMID 27477138 DOI: 10.1176/appi.ajp.2016.16030304r  0.36
2016 Issaria Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. The Journal of Clinical Psychiatry. 77: e605-11. PMID 27249090 DOI: 10.4088/JCP.14r09758  0.64
2016 Bloch MH, Panza KE, Yaffa A, Alvarenga PG, Jakubovski E, Mulqueen JM, Landeros-Weisenberger A, Leckman JF. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial. Journal of Child and Adolescent Psychopharmacology. PMID 27027204 DOI: 10.1089/cap.2015.0109  0.36
2015 Lebowitz ER, Panza KE, Bloch MH. Family accommodation in obsessive-compulsive and anxiety disorders: a five year update. Expert Review of Neurotherapeutics. PMID 26613396 DOI: 10.1586/14737175.2016.1126181  0.64
2015 Jakubovski E, Carlson JP, Bloch MH. Prognostic subgroups for remission, response, and treatment continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial. The Journal of Clinical Psychiatry. PMID 26581028 DOI: 10.4088/JCP.14m09320  0.64
2015 Jakubovski E, Bloch MH. Anxiety Disorder-Specific Predictors of Treatment Outcome in the Coordinated Anxiety Learning and Management (CALM) Trial. The Psychiatric Quarterly. PMID 26563229 DOI: 10.1007/s11126-015-9399-6  0.64
2015 Jakubovski E, Varigonda AL, Freemantle N, Taylor MJ, Bloch MH. Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. The American Journal of Psychiatry. appiajp201515030331. PMID 26552940 DOI: 10.1176/appi.ajp.2015.15030331  0.36
2015 Coughlin CG, Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Bloch MH. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26402485 DOI: 10.1089/cap.2015.0075  0.64
2015 Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF, Bloch MH. Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 728-36. PMID 26299294 DOI: 10.1016/j.jaac.2015.06.011  0.64
2015 Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, Kelmendi B, Sanacora G, Coric V. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. The Journal of Clinical Psychiatry. 76: 1075-84. PMID 26214725 DOI: 10.4088/JCP.14m09123  0.72
2015 Schumer MC, Panza KE, Mulqueen JM, Jakubovski E, Bloch MH. LONG-TERM OUTCOME IN PEDIATRIC TRICHOTILLOMANIA. Depression and Anxiety. 32: 737-43. PMID 26139231 DOI: 10.1002/da.22390  0.64
2015 Varigonda AL, Jakubovski E, Taylor MJ, Freemantle N, Coughlin C, Bloch MH. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 557-64. PMID 26088660 DOI: 10.1016/j.jaac.2015.05.004  0.64
2015 Alvarenga PG, do Rosario MC, Cesar RC, Manfro GG, Moriyama TS, Bloch MH, Shavitt RG, Hoexter MQ, Coughlin CG, Leckman JF, Miguel EC. Obsessive-compulsive symptoms are associated with psychiatric comorbidities, behavioral and clinical problems: a population-based study of Brazilian school children. European Child & Adolescent Psychiatry. PMID 26015374 DOI: 10.1007/s00787-015-0723-3  0.64
2015 Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstetrics and Gynecology. 125: 1224-35. PMID 25932852 DOI: 10.1097/AOG.0000000000000759  0.64
2015 Taylor JH, Jakubovski E, Bloch MH. Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial. Journal of Psychiatric Research. 65: 154-65. PMID 25896121 DOI: 10.1016/j.jpsychires.2015.03.020  0.64
2015 Jakubovski E, Bloch MH. Mr Jakubovski and Dr Bloch reply. The Journal of Clinical Psychiatry. 76: 327-8. PMID 25830452 DOI: 10.4088/JCP.14lr09483a  0.36
2015 Bloch MH, Storch EA. Assessment and management of treatment-refractory obsessive-compulsive disorder in children. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 251-62. PMID 25791142 DOI: 10.1016/j.jaac.2015.01.011  0.64
2015 Alvarenga PG, Cesar RC, Leckman JF, Moriyama TS, Torres AR, Bloch MH, Coughlin CG, Hoexter MQ, Manfro GG, Polanczyk GV, Miguel EC, do Rosario MC. Obsessive-compulsive symptom dimensions in a population-based, cross-sectional sample of school-aged children. Journal of Psychiatric Research. 62: 108-14. PMID 25702286 DOI: 10.1016/j.jpsychires.2015.01.018  0.64
2015 Kelly JM, Jakubovski E, Bloch MH. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial. The Journal of Clinical Psychiatry. 76: 267-78. PMID 25562579 DOI: 10.4088/JCP.13m08922  0.64
2015 Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, ... ... Bloch MH, et al. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. The American Journal of Psychiatry. 172: 82-93. PMID 25158072 DOI: 10.1176/appi.ajp.2014.13101306  0.64
2015 DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, Yang J, Wen R, Mann JJ, Krystal JH, Parsey RV, Carson RE, Esterlis I. In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5. Biological Psychiatry. 77: 266-75. PMID 25156701 DOI: 10.1016/j.biopsych.2014.06.024  0.64
2015 Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, Kelmendi B, Sanacora G, Coric V. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: A pilot randomized placebo-controlled trial Journal of Clinical Psychiatry. 76: 1075-1084. DOI: 10.4088/JCP.14m09123  0.64
2015 Leckman JF, Bloch MH. Tic disorders Rutter's Child and Adolescent Psychiatry: Sixth Edition. 757-773. DOI: 10.1002/9781118381953.ch56  0.64
2014 Bloch MH, Mulqueen J. Nutritional supplements for the treatment of ADHD. Child and Adolescent Psychiatric Clinics of North America. 23: 883-97. PMID 25220092 DOI: 10.1016/j.chc.2014.05.002  0.64
2014 Pittenger C, Bloch MH. Pharmacological treatment of obsessive-compulsive disorder. The Psychiatric Clinics of North America. 37: 375-91. PMID 25150568 DOI: 10.1016/j.psc.2014.05.006  0.64
2014 Adelman CB, Panza KE, Bartley CA, Bontempo A, Bloch MH. A meta-analysis of computerized cognitive-behavioral therapy for the treatment of DSM-5 anxiety disorders. The Journal of Clinical Psychiatry. 75: e695-704. PMID 25093485 DOI: 10.4088/JCP.13r08894  0.64
2014 McGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Cappi C, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, ... ... Bloch MH, et al. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 910-9. PMID 25062598 DOI: 10.1016/j.jaac.2014.04.022  0.64
2014 Bloch MH, Bartley CA, Zipperer L, Jakubovski E, Landeros-Weisenberger A, Pittenger C, Leckman JF. Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive-compulsive disorder. Molecular Psychiatry. 19: 1025-30. PMID 24912494 DOI: 10.1038/mp.2014.50  0.64
2014 Jakubovski E, Bloch MH. Prognostic subgroups for citalopram response in the STAR*D trial. The Journal of Clinical Psychiatry. 75: 738-47. PMID 24912106 DOI: 10.4088/JCP.13m08727  0.64
2014 Bloch MH. Meta-analysis and moderator analysis: can the field develop further? Journal of the American Academy of Child and Adolescent Psychiatry. 53: 135-7. PMID 24472248 DOI: 10.1016/j.jaac.2013.12.001  0.64
2014 Castellan Baldan L, Williams KA, Gallezot JD, Pogorelov V, Rapanelli M, Crowley M, Anderson GM, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza KE, Ercan-Sencicek AG, Krusong K, Leventhal BL, ... ... Bloch MH, et al. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron. 81: 77-90. PMID 24411733 DOI: 10.1016/j.neuron.2013.10.052  0.64
2014 Anticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, Repovs G, Cole MW, Bednarski S, Krystal JH, Bloch MH, Li CS, Pittenger C. Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biological Psychiatry. 75: 595-605. PMID 24314349 DOI: 10.1016/j.biopsych.2013.10.021  0.64
2014 Leckman JF, King RA, Bloch MH. Clinical features of Tourette syndrome and tic disorders Journal of Obsessive-Compulsive and Related Disorders. 3: 372-379. DOI: 10.1016/j.jocrd.2014.03.004  0.64
2014 Bloch MH, Lennington JB, Szuhay G, Lombroso PJ. Obsessive-Compulsive Disorder Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 1301-1310. DOI: 10.1016/B978-0-12-410529-4.00106-6  0.64
2014 Fritzen FM, Bloch MH. N-acetylcysteine for the treatment of obsessive-compulsive disorder Current Psychiatry Reviews. 10: 308-316.  0.64
2013 Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, ... Bloch MH, et al. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. Plos Genetics. 9: e1003864. PMID 24204291 DOI: 10.1371/journal.pgen.1003864  0.64
2013 Sukhodolsky DG, Bloch MH, Panza KE, Reichow B. Cognitive-behavioral therapy for anxiety in children with high-functioning autism: a meta-analysis. Pediatrics. 132: e1341-50. PMID 24167175 DOI: 10.1542/peds.2013-1193  0.64
2013 Bartley CA, Bloch MH. Meta-analysis: pharmacological treatment of pathological gambling. Expert Review of Neurotherapeutics. 13: 887-94. PMID 23952195 DOI: 10.1586/14737175.2013.814938  0.64
2013 Driesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun VD, D'Souza DC, Gueorguieva R, He G, Leung HC, Ramani R, Anticevic A, Suckow RF, Morgan PT, Krystal JH. The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2613-22. PMID 23856634 DOI: 10.1038/npp.2013.170  0.64
2013 Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. Plos One. 8: e63773. PMID 23691095 DOI: 10.1371/journal.pone.0063773  0.64
2013 Niciu MJ, Grunschel BD, Corlett PR, Pittenger C, Bloch MH. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder. Journal of Psychopharmacology (Oxford, England). 27: 651-4. PMID 23676198 DOI: 10.1177/0269881113486718  0.64
2013 Bartley CA, Hay M, Bloch MH. Meta-analysis: aerobic exercise for the treatment of anxiety disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 45: 34-9. PMID 23643675 DOI: 10.1016/j.pnpbp.2013.04.016  0.64
2013 Bloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, Landeros-Weisenberger A, Kelmendi B, Goodman WK, Leckman JF, Coric V, Pittenger C. Long-term outcome in adults with obsessive-compulsive disorder. Depression and Anxiety. 30: 716-22. PMID 23532944 DOI: 10.1002/da.22103  0.64
2013 Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 43: 2435-41. PMID 23468071 DOI: 10.1007/s10803-013-1793-z  0.64
2013 Panza KE, Pittenger C, Bloch MH. Age and gender correlates of pulling in pediatric trichotillomania. Journal of the American Academy of Child and Adolescent Psychiatry. 52: 241-9. PMID 23452681 DOI: 10.1016/j.jaac.2012.12.019  0.64
2013 Bloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. Journal of the American Academy of Child and Adolescent Psychiatry. 52: 231-40. PMID 23452680 DOI: 10.1016/j.jaac.2012.12.020  0.64
2013 Kichuk SA, Torres AR, Fontenelle LF, Rosário MC, Shavitt RG, Miguel EC, Pittenger C, Bloch MH. Symptom dimensions are associated with age of onset and clinical course of obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 44: 233-9. PMID 23410525 DOI: 10.1016/j.pnpbp.2013.02.003  0.64
2013 Driesen NR, McCarthy G, Bhagwagar Z, Bloch M, Calhoun V, D'Souza DC, Gueorguieva R, He G, Ramachandran R, Suckow RF, Anticevic A, Morgan PT, Krystal JH. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Molecular Psychiatry. 18: 1199-204. PMID 23337947 DOI: 10.1038/mp.2012.194  0.64
2013 Qawasmi A, Landeros-Weisenberger A, Bloch MH. Meta-analysis of LCPUFA supplementation of infant formula and visual acuity. Pediatrics. 131: e262-72. PMID 23248232 DOI: 10.1542/peds.2012-0517  0.64
2013 Cohen SC, Leckman JF, Bloch MH. Clinical assessment of Tourette syndrome and tic disorders. Neuroscience and Biobehavioral Reviews. 37: 997-1007. PMID 23206664 DOI: 10.1016/j.neubiorev.2012.11.013  0.64
2013 Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neuroscience and Biobehavioral Reviews. 37: 1162-71. PMID 23099282 DOI: 10.1016/j.neubiorev.2012.09.008  0.64
2012 Bloch MH. Misplaced Fear? FDA Contraindication to Psychostimulant Use in Children with Tics. Evidence-Based Child Health : a Cochrane Review Journal. 7: 1231-1234. PMID 25152702 DOI: 10.1002/ebch.1862  0.64
2012 Anticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, Niciu MJ, Morgan PT, Surti TS, Bloch MH, Ramani R, Smith MA, Wang XJ, Krystal JH, Corlett PR. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 109: 16720-5. PMID 23012427 DOI: 10.1073/pnas.1208494109  0.64
2012 Bloch MH, Wasylink S, Landeros-Weisenberger A, Panza KE, Billingslea E, Leckman JF, Krystal JH, Bhagwagar Z, Sanacora G, Pittenger C. Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biological Psychiatry. 72: 964-70. PMID 22784486 DOI: 10.1016/j.biopsych.2012.05.028  0.64
2012 Qawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH. Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition. Pediatrics. 129: 1141-9. PMID 22641753 DOI: 10.1542/peds.2011-2127  0.64
2012 Bontempo A, Panza KE, Bloch MH. D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis. The Journal of Clinical Psychiatry. 73: 533-7. PMID 22579153 DOI: 10.4088/JCP.11r07356  0.64
2012 Carrasco M, Volkmar FR, Bloch MH. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics. 129: e1301-10. PMID 22529279 DOI: 10.1542/peds.2011-3285  0.64
2012 Gray SM, Bloch MH. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Current Psychiatry Reports. 14: 220-8. PMID 22477442 DOI: 10.1007/s11920-012-0272-0  0.64
2012 Chalita PJ, Palacios L, Cortes JF, Landeros-Weisenberger A, Panza KE, Bloch MH. Relationship of dropout and psychopathology in a high school sample in Mexico. Frontiers in Psychiatry. 3: 20. PMID 22419912 DOI: 10.3389/fpsyt.2012.00020  0.64
2012 Lebowitz ER, Panza KE, Su J, Bloch MH. Family accommodation in obsessive-compulsive disorder. Expert Review of Neurotherapeutics. 12: 229-38. PMID 22288678 DOI: 10.1586/ern.11.200  0.64
2012 Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Molecular Psychiatry. 17: 1272-82. PMID 21931319 DOI: 10.1038/mp.2011.100  0.64
2012 Bloch MH, Hannestad J. Response to critiques on Omega-3 fatty acids for the treatment of depression: Systematic review and meta-analysis Molecular Psychiatry. 17: 1163-1167. DOI: 10.1038/mp.2012.116  0.64
2011 Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacology & Therapeutics. 132: 314-32. PMID 21963369 DOI: 10.1016/j.pharmthera.2011.09.006  0.64
2011 Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry. 50: 991-1000. PMID 21961774 DOI: 10.1016/j.jaac.2011.06.008  0.64
2011 Hannestad J, Dellagioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: A meta-analysis Neuropsychopharmacology. 36: 2452-2459. PMID 21796103 DOI: 10.1038/npp.2011.132  0.64
2011 Jakubovski E, Pittenger C, Torres AR, Fontenelle LF, do Rosario MC, Ferrão YA, de Mathis MA, Miguel EC, Bloch MH. Dimensional correlates of poor insight in obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1677-81. PMID 21640153 DOI: 10.1016/j.pnpbp.2011.05.012  0.64
2011 Bloch M, State M, Pittenger C. Recent advances in Tourette syndrome Current Opinion in Neurology. 24: 119-125. PMID 21386676 DOI: 10.1097/WCO.0b013e328344648c  0.64
2011 Bloch MH, Sukhodolsky DG, Dombrowski PA, Panza KE, Craiglow BG, Landeros-Weisenberger A, Leckman JF, Peterson BS, Schultz RT. Poor fine-motor and visuospatial skills predict persistence of pediatric-onset obsessive-compulsive disorder into adulthood. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 52: 974-83. PMID 21244423 DOI: 10.1111/j.1469-7610.2010.02366.x  0.64
2011 Reyes MM, Panza KE, Martin A, Bloch MH. Time-lag bias in trials of pediatric antidepressants: a systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry. 50: 63-72. PMID 21156271 DOI: 10.1016/j.jaac.2010.10.008  0.64
2011 Palermo SD, Bloch MH, Craiglow B, Landeros-Weisenberger A, Dombrowski PA, Panza K, Smith ME, Peterson BS, Leckman JF. Predictors of early adulthood quality of life in children with obsessive-compulsive disorder. Social Psychiatry and Psychiatric Epidemiology. 46: 291-7. PMID 20191262 DOI: 10.1007/s00127-010-0194-2  0.64
2011 Bloch MH. Trichotillomania and other impulse control disorders Clinical Obsessive-Compulsive Disorders in Adults and Children. 207-215. DOI: 10.1017/CBO9780511973796.016  0.64
2010 Bloch MH, Pittenger C. The Genetics of Obsessive-Compulsive Disorder. Current Psychiatry Reviews. 6: 91-103. PMID 23970845 DOI: 10.2174/157340010791196439  0.64
2010 Landeros-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. Journal of Affective Disorders. 121: 175-9. PMID 19577308 DOI: 10.1016/j.jad.2009.06.010  0.64
2010 Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry. 15: 850-5. PMID 19468281 DOI: 10.1038/mp.2009.50  0.64
2009 Bloch MH, Leckman JF. Clinical course of Tourette syndrome. Journal of Psychosomatic Research. 67: 497-501. PMID 19913654 DOI: 10.1016/j.jpsychores.2009.09.002  0.64
2009 Bloch MH, Craiglow BG, Landeros-Weisenberger A, Dombrowski PA, Panza KE, Peterson BS, Leckman JF. Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics. 124: 1085-93. PMID 19786445 DOI: 10.1542/peds.2009-0015  0.64
2009 Bloch MH. Trichotillomania across the life span. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 879-83. PMID 19692854 DOI: 10.1097/CHI.0b013e3181ae09f3  0.64
2009 Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 884-93. PMID 19625978 DOI: 10.1097/CHI.0b013e3181b26e9f  0.64
2009 Leckman JF, Bloch MH, King RA. Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective. Dialogues in Clinical Neuroscience. 11: 21-33. PMID 19432385  0.64
2008 Stubbe D, Martin A, Bloch M, Belitsky R, Carter D, Ebert M, Friedman A, Giese A, Kirwin P, Ross RG, Leckman JF. Model curriculum for academic child and adolescent psychiatry training. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. 32: 366-76. PMID 18945975 DOI: 10.1176/appi.ap.32.5.366  0.64
2008 Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. The American Journal of Psychiatry. 165: 1532-42. PMID 18923068 DOI: 10.1176/appi.ajp.2008.08020320  0.64
2008 Leckman JF, Bloch MH. A developmental and evolutionary perspective on obsessive-compulsive disorder: whence and whither compulsive hoarding? The American Journal of Psychiatry. 165: 1229-33. PMID 18829875 DOI: 10.1176/appi.ajp.2008.08060891  0.64
2008 Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G. Riluzole in the treatment of mood and anxiety disorders. Cns Drugs. 22: 761-86. PMID 18698875 DOI: 10.2165/00023210-200822090-00004  0.64
2008 Pittenger C, Kelmendi B, Wasylink S, Bloch MH, Coric V. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up. Journal of Clinical Psychopharmacology. 28: 363-7. PMID 18480706 DOI: 10.1097/JCP.0b013e3181727548  0.64
2008 Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 850-8. PMID 18186076 DOI: 10.1002/ajmg.b.30699  0.64
2008 Bloch MH, Landeros-Weisenberger A, Dombrowski P, Nudel J, Pittenger C, Leckman JF, Kelmendi B, Wegner R, Coric V. Response to Chamberlain et al. Re: Systematic Review: Pharmacological and Behavioral Treatments for Trichotillomania Biological Psychiatry. 63: e34-e35. DOI: 10.1016/j.biopsych.2008.01.022  0.64
2008 Bloch MH. Emerging treatment for Tourette's disorder Current Psychiatry Reports. 10: 323-330. DOI: 10.1007/s11920-008-0052-z  0.64
2007 Bloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wegner R, Nudel J, Pittenger C, Leckman JF, Coric V. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biological Psychiatry. 62: 839-46. PMID 17727824 DOI: 10.1016/j.biopsych.2007.05.019  0.64
2007 Coric V, Kelmendi B, Pittenger C, Wasylink S, Bloch MH, Green J. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania. The Journal of Clinical Psychiatry. 68: 170-1. PMID 17284151  0.64
2007 Martin A, Bloch M, Pruett K, Stubbe D, Belitsky R, Ebert M, Leckman JF. From Too Little Too Late to Early and Often: Child Psychiatry Education During Medical School (and Before and After) Child and Adolescent Psychiatric Clinics of North America. 16: 17-43. PMID 17141116 DOI: 10.1016/j.chc.2006.07.005  0.64
2007 Leckman JF, Bloch MH. Tourette's Syndrome Molecular Neurology. 385-408. DOI: 10.1016/B978-012369509-3.50027-5  0.64
2006 Leckman JF, Bloch MH, Scahill L, King RA. Tourette syndrome: the self under siege. Journal of Child Neurology. 21: 642-9. PMID 16970864 DOI: 10.1016/B978-0-12-410529-4.00107-8  0.64
2006 Bloch MH, Sukhodolsky DG, Leckman JF, Schultz RT. Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 47: 551-9. PMID 16712631 DOI: 10.1111/j.1469-7610.2005.01561.x  0.64
2006 Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry. 11: 622-32. PMID 16585942 DOI: 10.1038/sj.mp.4001823  0.64
2006 Leckman JF, Bloch MH, King RA, Scahill L. Phenomenology of tics and natural history of tic disorders. Advances in Neurology. 99: 1-16. PMID 16536348  0.64
2006 Bloch MH, Peterson BS, Scahill L, Otka J, Katsovich L, Zhang H, Leckman JF. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Archives of Pediatrics & Adolescent Medicine. 160: 65-9. PMID 16389213 DOI: 10.1001/archpedi.160.1.65  0.64
2006 Pittenger C, Bloch M, Wegner R, Teitelbaum C, Krystal JH, Coric V. Glutamatergic dysfunction in obsessive-compulsive disorder and the potential clinical utility of glutamate-modulating agents Primary Psychiatry. 13: 65-77.  0.64
2005 Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology. 65: 1253-8. PMID 16247053 DOI: 10.1212/01.wnl.0000180957.98702.69  0.64
2004 Bloch MH, Hwang WC, Baehring JM, Chambers SK. Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome. Obstetrics and Gynecology. 104: 1174-7. PMID 15516442 DOI: 10.1097/01.AOG.0000128110.31784.c8  0.64
Show low-probability matches.